BMO Capital Markets recommend investors to focus on smaller caps within growth stocks (NYSEARCA:SPYG), (NYSEARCA:VOOG), ...

Allworth Financial LP grew its stake in shares of ARK Fintech Innovation ETF (NYSEARCA:ARKF – Free Report) by 89.7% during ...

Discover why PGX's inefficiencies may cost you returns. Explore alternatives offering higher yields, better credit ratings, ...

Principal Securities Inc. grew its position in shares of Invesco S&P 500 Revenue ETF (NYSEARCA:RWL – Free Report) by 21.6% ...

JPMorgan’s global market strategy team indicated on Monday morning that equity markets for the most part have shrugged off ...

JPMorgan Chase Financial Company LLC announced today the quarterly coupon amount for the Alerian MLP Index ETN (NYSE Arca: ...

Things have been looking up for Cathie Wood’s flagship Ark Innovation ETF (NYSEARCA:ARKK) since bouncing off last year’s ...

Following several weeks of widespread buying across most commodities and sectors, hedge funds began to exhibit signs of ...

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Revaluing the U.S. gold reverses would result in an estimated $760 billion, creating a windfall of $749 billion.